Towards understanding the peripheral T-cell lymphomas

Annals of Oncology

Volumn 15, Issue 10, 2004, Pages 1447-1449

  Armitage, J O ^a   Vose, J M ^a   Weisenburger, D D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DEPSIPEPTIDE; DEXAMETHASONE; DOXORUBICIN; INTERFERON; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; NULL CELL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 6944238457     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh409     Document Type: Editorial

References (21)

1. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: Jaffe E, Harris N, Stein H, Vardiman J (eds): World Health Organization Classification of Tumors. Lyon: IARC Press 2001.
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
3. Rudiger T, Weisenburger DD, Anderson JR et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140-149.
4. Weisenburger DD, Anderson JR, Diebold J et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol 2001; 67: 172-178.
5. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780-2795.
6. Armitage JO, Vose JM, Linder J et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 1989; 7: 1783-1790.
7. Brown DC, Heryet A, Gatter KC, Mason DY. The prognostic significance of immunophenotype in high-grade non-Hodgkin's lymphoma. Histopathology 1989; 14: 621-627.
8. Cheng AL, Chen YC, Wang CH et al. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - should peripheral T-cell lymphoma be considered separately? J Clin Oncol 1989; 7: 725-731.
9. Shimizu K, Hamajima N, Ohnishi K, Hara K, Kunii A. T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma. Jpn J Cancer Res 1989; 80: 720-726.
10. Lippman SM, Miller TP, Spier CM, Slymen DJ, Grogan TM. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988; 72: 436-441.
11. Coiffier B, Brousse N, Peuchmaur M et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1990; 1: 45-50.
12. Kwak LW, Wilson M, Weiss LM et al. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience. J Clin Oncol 1991; 9: 1426-1431.
13. Shimoyama M, Oyama A, Tajima K et al. Differences in clinico-pathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma. Leuk Lymphoma 1993; 10: 335-342.
14. Gascoyne RD, Aoun P, Wu D et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913-3921.
15. Brugieres L, Deley MC, Pacquement H et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998; 92: 3591-3598.
16. Falini B, Pileri S, Zinzani PL et al. ALK + lymphoma: clinico-pathological findings and outcome. Blood 1999; 93: 2697-2706.
17. Rodriguez J, Munsell M, Yazji S et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766-3770.
18. Rodriguez J, Caballero MD, Gutierrez A et al. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 2003; 14: 1768-1775.
19. Vose JM, Peterson C, Bierman PJ et al. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphoma. Blood 1990; 76: 424-431.
20. Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467-1475.
21. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998; 9: 717-720.